Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXTL4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,089
Award facts
- Contract value 100% obligated
- $13,088.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,088.85 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 10, 2026, for the supply of Cosentyx Unoready 300 mg pen injections (2 mL). This non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. The delivery order represents a task order issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated extensive capability in fulfilling federal medical procurement requirements through its competitive awards and substantial portfolio of pharmaceutical deliveries to military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and maintains a critical role in the Defense Logistics Agency's medical supply chain, delivering medications across multiple therapeutic domains including specialty treatments, brand-name and generic drugs, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXTL4?
SPE2DR26FXTL4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 10, 2026.
How much is contract SPE2DR26FXTL4 worth?
The government has obligated $13,089 on SPE2DR26FXTL4.
Is contract SPE2DR26FXTL4 an order under another contract?
Yes. SPE2DR26FXTL4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTL4 competed?
The extent of competition for SPE2DR26FXTL4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award